Viridian Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Viridian Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Viridian Therapeutics Inc
Rating: 1.13477775
Author: Trendlyne DVM scores

Momentum Trap

about

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligr...

27.64 -0.96 (-3.36%)

179.19% Gain from 52W Low

558.2K

XNAS Volume

XNAS 18 Mar, 2026 3:23 PM (EDT)

Low Financial Strength

11.1 / 100

Expensive Valuation

9.0 / 100

Technically Neutral

59.6 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 51%

17 analysts

Viridian Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Viridian Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligr...

179.19% Gain from 52W Low

SWOT Analysis

Viridian Therapeutics Inc Live Price Chart